drugset / Trial / NCT01147718

A Drug Interaction Study of Albiglutide and Digoxin

NCT01147718

Phase 1 Completed 30 enrolled GlaxoSmithKline
NaSingle-groupOpen-labelBasic science

Summary

This Phase I, open-label, sequential, single-center study evaluates the pharmacokinetics of digoxin when coadministered with albiglutide in healthy adult subjects.

Timeline

Start
2010-06-11
Primary completion
2010-11-29
Completion
2010-11-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Digoxin Other / unclassified 0.5 mg
Subject albiglutide Peptide Subcutaneous